Journal profile · Substance Abuse
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH
ISSN 0145-6008 · eISSN 2993-7175 · Wiley-Blackwell · UNITED STATES · Monthly · Founded 1977
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.4 (journal website); hybrid open access; APC about USD 4,110; median 156 days to acceptance (95 articles, last 24 months); community-reported acceptance: fairly easy; 265 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH is published by Wiley-Blackwell and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Alcohol Consumption and Health Effects, Substance Abuse Treatment and Outcomes and Neurotransmitter Receptor Influence on Behavior, together about 49.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Aims Alcohol, Clinical and Experimental Research's aims are: to provide an effective forum for high quality research in the field of alcoholism by ensuring careful peer review and selection of the highest quality papers. to share new findings with others in the alcohol research field and beyond on matters relating to the science or its translation into clinical practice or policy. to disseminate high quality research in the field of alcoholism worldwide through its publication. Scope Alcohol, Clinical and Experimental Research's scope spans animal and human clinical research, epidemiological, experimental, policy, and historical research relating to any aspect of alcohol abuse, dependence, or alcoholism. This journal uses a multi-disciplinary approach in its scope of alcoholism, its causes, clinical and animal effect, consequences, patterns, treatments and recovery, predictors and prevention.
From the journal's Aims & Scope
Research area (LetPub): Substance Abuse
Editorial board by country: none in mainland China; most named United States 58, Australia 4, Germany 2, Canada 2, Japan 1 (69 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Alcohol Consumption and Health EffectsMedicine21%
- Substance Abuse Treatment and OutcomesMedicine16.5%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience12.1%
- Prenatal Substance Exposure EffectsMedicine9.3%
- Alcoholism and Thiamine DeficiencyMedicine7.9%
- Neuroscience and Neuropharmacology ResearchNeuroscience3.8%
- Liver Disease Diagnosis and TreatmentMedicine3.6%
- Stress Responses and CortisolNeuroscience2.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Substance Abuse | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Substance Abuse | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Substance Abuse | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbasePsycINFOCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.4Publisher website ·
- Impact factor (publisher) 2025
- 2.4Publisher website ·
- CiteScore 2026-06
- 5.9LetPub ·
- CiteScore (publisher)
- 4.4Publisher website ·
- CiteScore (publisher) 2025
- 4.4Publisher website ·
- SJR 2026-06
- 1.08LetPub ·
- SNIP 2026-06
- 1.12LetPub ·
- h-index
- 143LetPub ·
- h-index
- 222OpenAlex ·
- i10-index
- 8,476OpenAlex ·
- 2-year mean citedness
- 2.04OpenAlex ·
- Self-citation rate
- 8.3%LetPub ·
- Share of gold OA articles
- 41.39%LetPub ·
Volume
- Articles per year
- 205LetPub ·
- Articles per year (publisher)
- 2Publisher website ·
- Articles per year (publisher) 2025
- 220Publisher website ·
- Downloads per year (publisher) 2025
- 676,094Publisher website ·
Articles by year OpenAlex count · 14,862 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 190 | 141 | 47 |
| 2025 | 265 | 210 | 434 |
| 2024 | 268 | 217 | 994 |
| 2023 | 252 | 216 | 1,492 |
| 2022 | 250 | 172 | 2,745 |
| 2021 | 270 | 184 | 3,520 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
156 daysMedian, submission to acceptance · P25–P75 113 days – 194 days
- Acceptance to online
- —
- Submission to online
- —
- Sample
- 95 articles with submission and acceptance dates (466 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–6 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 49%Publisher website ·
- Acceptance rate (publisher) 2025
- 49%Publisher website ·
- Submission to first decision
- 32 daysPublisher website ·
- Submission to first decision 2025
- 32 daysPublisher website ·
- Submission to acceptance 2025
- 136 daysPublisher website ·
- Acceptance to publication 2025
- 27 daysPublisher website ·
- Submission to publication
- 4 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,110 / EUR 3,450 / GBP 2,750 | — | — | |
| Publisher website | USD 60 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted8, with length limits
- commentaryr arrangement with the Editor in-Chief. Commentaries are not to exceed 2500 words (excluding title page, abstract, references, tables and figmain text ≤ 2,500 words
- critical reviewsThe journal accepts both full-length papers and critical reviews.Length not stated
- editorial commentariesThe journal also publishes editorial commentaries.Length not stated
- feature articlesPapers that the editors consider to be of cross-disciplinary interest and significance may be highlighted as Feature Articles.Length not stated
- full-length papersThe journal accepts both full-length papers and critical reviews.Length not stated
- original researchIt is an online, peer-reviewed, multidisciplinary journal that publishes original research that contributes substantially to our understanding of the etiology, …Length not stated
- research articlebmitted for publication in the journal. Research articles: The recommended word limit for articles is 6000 words (excluding title page, abstract, references, ta…main text ≤ 6,000 words
- reviewThe recommended word limit for critical reviews of both types is 6000 words (excluding title page, abstract, references, tables, and fimain text ≤ 6,000 words
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Preprints
- Authorship
Original work only; not under consideration elsewhere; no republication without consent. Model summary
A submitted manuscript must be an original contribution not previously published (except as an abstract, a preliminary report, or on a pre-print server), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of the Research Society on Alcohol.
Source ↗Publisher website ·- Conflicts of interest
Conflict of interest disclosure required at submission; if none, authors must state this. Model summary
Conflict of Interest: This publication requires that all authors disclose any potential conflicts of interest. If the authors have no conflict of interest to declare, they must state this at submission.
Source ↗Publisher website ·- Data availability
Data archiving in a public repository expected. Model summary
ACER expects that data supporting the results in the paper will be archived in an appropriate public repository.
Source ↗Publisher website ·- Publication ethics
Patient anonymity and informed consent are the author's responsibility. Model summary
It is the author’s responsibility to ensure that a patient’s anonymity is carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all of the authors are affiliated.
Source ↗Publisher website ·- License & copyright
Written permission required for copyrighted material reuse. Model summary
Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source.
Source ↗Publisher website ·- Preprints
Preprint posting prior to submission is allowed. Model summary
An exception to the requirement that submissions have not previously been published is the posting of manuscripts on a pre-print server prior to its submission to ACER. This is allowed by ACER.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1977
- ISSN
- 0145-6008
- Print ISSN
- 2993-7175
- Electronic ISSN
- 2993-7175
- Society / sponsor
- Research Society on Alcohol and the International Society for Biomedical Research on Alcoholism
- Latest issue on the website
- Volume 50, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH
What CAS zone is ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH in?
In the 2025 upgraded edition of the CAS Journal Ranking, ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH is in Zone 3 of Medicine, and in Zone 3 of the minor category Substance Abuse. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH?
The journal's website gives an impact factor of 2.4 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 5.9, h-index 222.
How long does peer review take at ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH?
Based on the dates recorded on 95 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 156 days (interquartile range 113–194 days); authors report an average review time of 3–6 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 49% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH based?
Of the 69 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (58), Australia (4) and Germany (2). Counted from the institutions listed on the board page; for reference only.
Which databases index ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH?
According to LetPub and DOAJ records, ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, PsycINFO, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH open access, and what is the APC?
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH is a hybrid journal. For open-access publication: APC about USD 4,110.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .